Price Alert

Adaptive Biotechnologies ... (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

13.05

0.13 (1.01%)

At close: Aug 15, 2025, 1:21 PM

Adaptive Biotechnologies Statistics

Share Statistics

Adaptive Biotechnologies has 152.27M shares outstanding. The number of shares has increased by 3.01% in one year.

Shares Outstanding	152.27M
Shares Change (YoY)	3.01%
Shares Change (QoQ)	2.24%
Owned by Institutions (%)	99.99%
Shares Floating	145.25M
Failed to Deliver (FTD) Shares	1,506
FTD / Avg. Volume	0.08%

Short Selling Information

The latest short interest is 9.69M, so 6.38% of the outstanding shares have been sold short.

Short Interest	9.69M
Short % of Shares Out	6.38%
Short % of Float	8.17%
Short Ratio (days to cover)	5.43

Valuation Ratios

The PE ratio is -5.53 and the forward PE ratio is -19.63. Adaptive Biotechnologies's PEG ratio is 0.18.

PE Ratio	-5.53
Forward PE	-19.63
PS Ratio	4.93
Forward PS	6.9
PB Ratio	4.35
P/FCF Ratio	-8.93
PEG Ratio	0.18

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Adaptive Biotechnologies.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.44.

Current Ratio	2.89
Quick Ratio	2.81
Debt / Equity	0.44
Debt / EBITDA	-0.69
Debt / FCF	-0.9
Interest Coverage	-14.04

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$289.11K
Profits Per Employee	$-257.66K
Employee Count	619
Asset Turnover	0.33
Inventory Turnover	8.54

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 182.33% in the last 52 weeks. The beta is 1.93, so Adaptive Biotechnologies's price volatility has been higher than the market average.

Beta	1.93
52-Week Price Change	182.33%
50-Day Moving Average	10.84
200-Day Moving Average	8.09
Relative Strength Index (RSI)	65.13
Average Volume (20 Days)	1,898,979

Income Statement

In the last 12 months, Adaptive Biotechnologies had revenue of 178.96M and earned -159.49M in profits. Earnings per share was -1.08.

Revenue	178.96M
Gross Profit	106.88M
Operating Income	-162.55M
Net Income	-159.49M
EBITDA	-128.76M
EBIT	-148.01M
Earnings Per Share (EPS)	-1.08

Full Income Statement

Balance Sheet

The company has 47.92M in cash and 89.39M in debt, giving a net cash position of -41.47M.

Cash & Cash Equivalents	47.92M
Total Debt	89.39M
Net Cash	-41.47M
Retained Earnings	-1.3B
Total Assets	496.64M
Working Capital	169.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -95.21M and capital expenditures -3.66M, giving a free cash flow of -98.88M.

Operating Cash Flow	-95.21M
Capital Expenditures	-3.66M
Free Cash Flow	-98.88M
FCF Per Share	-0.67

Full Cash Flow Statement

Margins

Gross margin is 59.72%, with operating and profit margins of -90.83% and -89.12%.

Gross Margin	59.72%
Operating Margin	-90.83%
Pretax Margin	-89.18%
Profit Margin	-89.12%
EBITDA Margin	-71.95%
EBIT Margin	-90.83%
FCF Margin	-55.25%

Dividends & Yields

ADPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for ADPT is $13, which is 7.1% higher than the current price. The consensus rating is "Buy".

Price Target	$13
Price Target Difference	7.1%
Analyst Consensus	Buy
Analyst Count	8

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-0.26
Piotroski F-Score	4